New topics in the ACCP guideline include the perioperative management of patients receiving direct oral anticoagulants and P2Y12 inhibitor antiplatelet drugs.
Researchers sought to determine whether direct oral anticoagulant or warfarin would be better for recurrent VTE in patients taking extended anticoagulation treatment.
Researchers sought to determine the utilization of CHEST guidelines for administering anticoagulants for patients with subsegmental PE.
Researchers sought to determine the incidence of silent cerebral infarction in survivors of immune thrombotic thrombocytopenic purpura.
A study was conducted to assess clinical outcomes via 90-day home time in patients with medium-vessel occlusion treated with endovascular thrombectomy.
Researchers sought to determine the different characteristics for acute VTE in young adults and older adults.
Researchers sought to determine whether direct oral anticoagulants would do as well in preventing VTE in patients with cancer as LMW heparin
Researchers sought to determine whether lowering apixaban from the standard 5.0 mg twice daily dose to 2.5 mg twice daily would impact bleeding and thrombosis rates for patients with cancer.
Researchers sought to determine whether recombinant ADAMTS13 prophylaxis would be a viable therapy for patients with congenital thrombotic thrombocytopenic purpura.
Researchers sought to determine whether LMWH would lead to a reduction in the likelihood of developing a symptomatic confirmed VTE in hospitalized patients.
Researchers sought to determine whether recombinant ADAMTS13 would have clinical benefit for patients with iTTP.
Researchers sought to determine whether LMW heparin would increase the rate of live births seen in women with inherited thrombophilia and recurrent miscarriage.
Researchers sought to determine the resource utilization for patients with acute, low-risk pulmonary embolism.
Researchers sought to determine ADAMTS13 activity in a cohort of patients with iTTP receiving caplacizumab.
Venous thromboembolism occurred in the graft in 15.4% of patients.
Investigators sought to explore the relationships between clinical presentation of acute PE, patient characteristics, PE severity, and mortality.
Researchers sought to identify any links to venous thromboembolism in patients hospitalized for an eating disorder.
Researchers sought to determine the use of a pulmonary embolism rule-out criteria rule and its failure rate.
Researchers sought to determine whether early administration of 4F-PCC would reduce 24-hour blood product consumption in patients with trauma at risk of massive transfusion.
Researchers quantified the risks of bleeding and VTE associated with early VTE prophylaxis in critically ill patients with thrombocytopenia in a range of platelet counts.
Researchers evaluated whether patients with acne treated with spironolactone are at increased risk for venous thromboembolism.
Researchers sought to determine the impacts iTTP or aHUS have on patients’ quality of life and mental health.
Researchers sought to determine risk factors for VTE in pediatric patients hospitalized with acute hematogenous musculoskeletal infections.
Researchers sought to assess patients with acute iTTP with marked endothelium-mediated microvascular hyporeactivity.
Researchers sought to develop a machine learning algorithm to predict the risk of bleeding among patients with venous thromboembolism.
Swedish studies reveal significantly elevated risks for myocardial infarction, ischemic stroke, pulmonary embolism, and deep vein thrombosis.
Researchers sought to determine whether there is a link between presence of supernumerary sex chromosome aneuploidy and risk of VTE.
Researchers sought to determine bleeding risks for older patients treated with anticoagulation with vitamin K antagonists for the treatment of VTE.
Researchers sought to determine whether ADAMTS13 with an open confirmation would impact diagnosis in patients with iTTP.
Researchers sought to determine whether ABO blood type may impact the risk of developing VTE in patients with cancer.
Researchers sought to identify characteristics of adolescent compared with adult patients with acquired thrombotic thrombocytopenic purpura.
Researchers sought to determine whether using a D-dimer assay would help determine whether patients require extended treatment for VTE.
Researchers sought to develop implemented a machine-learning model for the diagnosis of heparin-induced thrombocytopenia.
Researchers sought to compare oral apixaban and subcutaneous dalteparin for treating patients with cancer-related venous thromboembolism.
Researchers sought to determine whether anticoagulation therapy using rivaroxaban would be effective in children with cancer-associated venous thromboembolism.
Researchers sought to identify genes related to complement dysfunction in patients with iTTP.
Researchers sought to determine the efficacy of a Mirasol®-based pathogen-reduction strategy for platelets.
Researchers sought to determine the risk of intraventricular hemorrhage and mortality in preterm infants with lower platelet counts.
Researchers sought to determine whether there was a link between abnormal menstrual bleeding and treatment with anticoagulants for VTE.
Researchers sought to determine whether the addition of IPC to thromboprophylaxis for prevention of VTE is based on sound evidence.
Regardless of vaccination status, adults hospitalized for COVID-19 infection are at increased risk for acute thromboembolism
Researchers sought to examine characteristics of and outcomes for patients with venothromboembolism and concomitant fibroids or gynecologic cancers.
Researchers sought to determine whether patients with cancer were aware of their risk of developing cancer-associated venous thromboembolism.
Researchers conducted an analysis of the Gab2-MALT1 pathway to determine whether it impacts the development of thromboinflammation and deep vein thrombosis.
Researchers sought to determine patters related to age and sex in outcomes for patients with CVT.
Researchers explored the use of D-dimer levels to rule out PTE in patients with COVID-19, as well as clinical associations between D-dimer levels and PTE.
Researchers assessed nationwide trends of venous thromboembolism-related hospitalizations among patients with inflammatory bowel disease.
Researchers assessed the 30-day risk for VTE among ambulatory patients with COVID-19 and compared, via propensity-score matching, individuals without COVID-19 infection.
Researchers assessed the relationship between oral anticoagulation for patients with COVID-19 and AF and incidence of in-hospital thrombotic events and death.
Researched compared standard vs variable thromboprophylaxis strategies on the risk of mortality among patients hospitalized with COVID-19.
Can the pulmonary embolism severity index assess the risk for adverse events among patients hospitalized for COVID-19 who are not diagnosed with PE or VTE?